95 related articles for article (PubMed ID: 20727868)
1. Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.
de Boer D; Houben C; Bekers O; Menheere PP
Clin Biochem; 2010 Nov; 43(16-17):1371-2. PubMed ID: 20727868
[TBL] [Abstract][Full Text] [Related]
2. [How do we quality-assure point-of-care diagnosis?].
Olcén P; Aberg AK; Fredlund H; Rönnelid J; Aspevall O; Truedsson L
Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3559-60. PubMed ID: 19133585
[No Abstract] [Full Text] [Related]
3. [Testing outside of the laboratory: stakes and perspectives].
Bailloux MC
Soins Chir; 1997 Jun; (183):29-31. PubMed ID: 9282090
[No Abstract] [Full Text] [Related]
4. Quality in point-of-care testing.
Nichols JH
Expert Rev Mol Diagn; 2003 Sep; 3(5):563-72. PubMed ID: 14510177
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.
Nerenz RD; Gronowski AM
Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957
[No Abstract] [Full Text] [Related]
6. Measuring quantitative serum human chorionic gonadotropin. Variations in levels between kits.
Smikle CB; Sorem KA; Wians FH; Hankins GD
J Reprod Med; 1995 Jun; 40(6):439-42. PubMed ID: 7650656
[TBL] [Abstract][Full Text] [Related]
7. Experience with an external quality assessment programme for point-of-care-testing (POCT) devices for the determination of blood glucose.
Wood WG; Hanke R; Meissner D; Reinauer H
Clin Lab; 2003; 49(3-4):151-9. PubMed ID: 12705698
[TBL] [Abstract][Full Text] [Related]
8. Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.
Parekh BS; Kalou MB; Alemnji G; Ou CY; Gershy-Damet GM; Nkengasong JN
Am J Clin Pathol; 2010 Oct; 134(4):573-84. PubMed ID: 20855638
[TBL] [Abstract][Full Text] [Related]
9. [Choose safe measurement methods for point-of-care analyses].
Lindstedt G
Lakartidningen; 2008 Nov 12-18; 105(46):3322. PubMed ID: 19062623
[No Abstract] [Full Text] [Related]
10. The role of POCT and rapid testing. Here is an overview of an evolving approach to direct patient care.
DuBois JA
MLO Med Lab Obs; 2013 Sep; 45(9):18, 20, 22. PubMed ID: 24147330
[No Abstract] [Full Text] [Related]
11. Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood.
Bertsch T; Dikkeschei B; Gurr E; Hayen W; Jørgensen B; Lotz J; Müller-Bardorff M; Ordóñez-Llanos J; Schulz I; Spinke J; Thiele M; Zerback R
Clin Lab; 2007; 53(7-8):423-31. PubMed ID: 17821946
[TBL] [Abstract][Full Text] [Related]
12. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
13. Performances of urine pregnancy tests on College of American Pathologists Survey specimens.
Biesecker JL; Rippey JH
Am J Clin Pathol; 1981 Oct; 76(4 Suppl):544-6. PubMed ID: 7282640
[TBL] [Abstract][Full Text] [Related]
14. Quality control for the point-of-care activated clotting time test.
Bonderman PW
Am Clin Lab; 1994 Dec-1995 Jan; 14(1):6-8. PubMed ID: 10163486
[No Abstract] [Full Text] [Related]
15. Assessment of the Abbott IMx assay system for the measurement of human chorionic gonadotropin levels in the treatment of ectopic pregnancy.
Goodman DB; Bulley M; Hendricks M; Senior M
Arch Pathol Lab Med; 1993 Jul; 117(7):701-3. PubMed ID: 8323432
[TBL] [Abstract][Full Text] [Related]
16. [POCT in coagulation. Quality assurance].
Spannagl M; Dick A; Junker R
Hamostaseologie; 2010 May; 30(2):82-90. PubMed ID: 20454752
[TBL] [Abstract][Full Text] [Related]
17. [Immunological assay of chorionic gonadotropin during pregnancy. Multicenter study of 5 reagents].
Patricot MC; Badonnel Y; Roger M; Revol A
Ann Biol Clin (Paris); 1987; 45(5):527-31. PubMed ID: 3322114
[TBL] [Abstract][Full Text] [Related]
18. [Chemistry and immunoreactivity of human chorionic gonadotropin (hCG)].
Ishiguro M
Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):170-82. PubMed ID: 3321161
[No Abstract] [Full Text] [Related]
19. Comment on: Point-of-care testing for malaria outbreak management.
Arya SC; Agarwal N
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):106; author reply 106. PubMed ID: 18760434
[No Abstract] [Full Text] [Related]
20. Improved performance of point-of-care and over-the-counter qualitative human chorionic gonadotropin measurement devices.
Nerenz RD; Gronowski AM
Clin Chem; 2014 Dec; 60(12):1576-8. PubMed ID: 25161145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
